Transforming Patient Access To CGT: Q&A With Aruna Mor

Aruna Mor, Chief Commercial Officer at Cryoport Systems, recently delivered a compelling keynote address at the Advanced Therapies Congress in London, where she illuminated the complex challenges surrounding patient access to cutting-edge therapies. In her speech, she outlined the critical steps necessary to break down these barriers and ensure that life-saving treatments are more widely available.

We had the privilege of sitting down with Aruna to further explore the key themes of her presentation. In our conversation, we examined the intricate intersection of science, logistics, supply chain management, regulation, and collaboration—the core factors that will shape the future of Cell and Gene Therapy (CGT). Aruna shared her valuable insights into the current landscape of the CGT industry, highlighting the pivotal role of global collaboration in overcoming obstacles and driving progress.

She also offered a forward-looking perspective on the path ahead, stressing the importance of overcoming logistical and regulatory challenges to ensure these transformative therapies can reach the patients who need them the most. With her expertise, Aruna provided a clear vision for the future, emphasizing the need for continued innovation and cooperation to unlock the full potential of CGT and revolutionize patient care.